The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.
Kaitlyn Dever has quickly emerged as one of the standout stars of her generation, establishing herself as one of the most ...
Hosted on MSN22d
Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContinThe deal, agreed to by Purdue Pharma, the Sackler family members who own the company ... every time someone got hooked — getting rich with no regard to the toll their drugs were taking on people, ...
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma, over their actions leading up to the opioid crisis, which has killed ...
“This epidemic, no doubt, was fueled by Purdue Pharma’s manufacturing and deceptive marketing of OxyContin, a highly potent and addictive drug.” The specific terms require the Sacklers to ...
Purdue Pharma will pay more than $7 billion for the corporation's ... the settlement in addressing the commonwealth's public health crisis. "Dependency on the drug ruined countless lives, while the ...
The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
NEW YORK, Jan 23 (Reuters) - Purdue Pharma and its Sackler family owners ... The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results